Kevin Cowart

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

Clinical diabetes : a publication of the American Diabetes Association

The Annals of pharmacotherapy

Journal of diabetes science and technology

Diabetes, obesity & metabolism

University of South Florida

University of Florida College of Public Health & Health Professions (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of South Florida May 01 2018

United States

Assistant Professor :: Department of Pharmacotherapeutics & Clinical Research

Education History

University of Florida College of Public Health & Health Professions

United States

MSC

University of South Florida College of Pharmacy

United States

PHD

Publications

Kevin Cowart, Angelina Vascimini, Ambuj Kumar, Athanasios Tsalatsanis, Yalda Saba, Nicholas W Carris
Impact of Overbasalization on Clinical Outcomes in Patients With Type 2 Diabetes: A Post Hoc Analysis of a Large Randomized Controlled Trial. Clinical diabetes : a publication of the American Diabetes Association 41 (2) (2023)
Kevin Cowart, Angelina Vascimini, Ambuj Kumar, Athanasios Tsalatsanis, Yalda Saba, Nicholas W Carris
Impact of Overbasalization on Clinical Outcomes in Patients With Type 2 Diabetes: A Post Hoc Analysis of a Large Randomized Controlled Trial. Clinical diabetes : a publication of the American Diabetes Association 41 (2) (2023)
Kevin Cowart, Angelina Vascimini, Ambuj Kumar, Athanasios Tsalatsanis, Yalda Saba, Nicholas W Carris
Impact of Overbasalization on Clinical Outcomes in Patients With Type 2 Diabetes: A Post Hoc Analysis of a Large Randomized Controlled Trial. Clinical diabetes : a publication of the American Diabetes Association 41 (2) (2023)
Kevin Cowart, Angelina Vascimini, Ambuj Kumar, Athanasios Tsalatsanis, Yalda Saba, Nicholas W Carris
Impact of Overbasalization on Clinical Outcomes in Patients With Type 2 Diabetes: A Post Hoc Analysis of a Large Randomized Controlled Trial. Clinical diabetes : a publication of the American Diabetes Association 41 (2) (2023)
Kevin Cowart, Scott Coon, Nicholas W Carris
A Review of the Safety and Efficacy of Bexagliflozin for the Management of Type 2 Diabetes. The Annals of pharmacotherapy (2023)
Kevin Cowart, Vidhi Patel, Jessica Bianco, Amanda Martinez, Jason Castro
Pharmacist-Physician Collaborative Practice to Improve Diabetes Care at Tampa General Medical Group. Clinical diabetes : a publication of the American Diabetes Association 40 (2) (2022)
Kevin Cowart, Wendy H Updike, Rachel Franks
Continuous glucose monitoring in persons with type 2 diabetes not using insulin. Expert review of medical devices 18 (11) (2021)
Kevin Cowart, Janice Zgibor
Flash Continuous Glucose Monitoring: A Practical Guide and Call to Action for Pharmacists. Journal of pharmacy practice (2021)
Kevin Cowart, Nnadozie Emechebe, Rashmi Pathak, Lucas Abbruzese, James Hann, Andie Lloyd, Richard Roetzheim, Janice Zgibor, Wendy H Updike
Measurement of Pharmacist-Physician Collaborative Care on Therapeutic Inertia in Patients With Type 2 Diabetes. The Annals of pharmacotherapy (2021)
Kevin Cowart, Rachel Gonzalez, Nicholas W Carris
Cardiovascular and microvascular outcomes with iGlarLixi versus iDegLira: A real-world, population-based cohort study. Diabetes, obesity & metabolism (2021)
Kevin Cowart, Nicholas W Carris
Evaluation of cardiovascular and renal outcomes with ertugliflozin: what is the VERdict from the VERTIS-CV trial? Expert opinion on pharmacotherapy 22 (2) (2020)
Kevin Cowart, Wendy H Updike, Andie Lloyd, Krystal Bullers
Anticipatory guidance and systematic review of prescribing combination incretin therapy in the treatment of type 2 diabetes. Journal of clinical pharmacy and therapeutics 46 (1) (2020)
Kevin Cowart, Marylee Worley, Nihal El Rouby, Karen Sando
Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections. The Annals of pharmacotherapy 53 (12) (2019)
Kevin Cowart
Oral Semaglutide: First-in-Class Oral GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes Mellitus. The Annals of pharmacotherapy 54 (5) (2019)
Kevin Cowart
A Review of the First Long-term Implantable Continuous Glucose Monitoring System Available in the United States. Journal of diabetes science and technology 15 (1) (2019)

Kevin Cowart.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kevin Cowart